Raman spectral analysis of pathogens

ABSTRACT

Raman scattering of radiation applied to a water sample is used to assess occurrence of a pathogen in the sample. The method is useful for detecting pathogens that are difficult to detect using other methods, such as protozoa. Examples of organisms that can be detected in water samples using these methods include protozoa of the genus  Cryptosporidium  and the genus  Giardia.  The methods described herein have important applications, such as for detection of  Cryptosporidium  organisms in municipal water systems.

CROSS-REFERENCES TO RELATED APPLICATIONS

This application is a continuation-in-part of co-pending U.S.application Ser. No. 10/922,006 (now allowed), filed 18 Aug. 2004, whichis a continuation-in-part of U.S. application Ser. No. 10/823,902 filed14 Apr. 2004, which is a continuation of U.S. application Ser. No.10/339,807, filed 10 Jan. 2003, which is now issued as U.S. Pat. No.6,765,668, and is entitled to priority pursuant to 35 U.S.C. § 119(e) toU.S. provisional patent application 60/347,806, which was filed on 10Jan. 2002. The entirety of each of these applications is incorporatedherein by reference.

BACKGROUND OF THE INVENTION

The invention relates generally to the field of assessing occurrence ofchemical and biological pathogens in water, other fluids, particles,concentrated environmental samples, and other milieu.

There are two primary sources of drinking water. The first source,ground water, can be extracted either at springs at which it naturallywells up to the surface or from wells sunk into the earth. Surface wateris the second source, and is collected from bodies of stationary ormoving water on the surface of the earth, such as rivers, lakes, andreservoirs. Ground water ordinarily accumulates by percolating downwardfrom the surface to underground formations, and is naturally filteredsuch that it rarely contains particulates carried downwards from thesurface. On the other hand, particulates which find their way intosurface water can remain suspended therein for significant periods oftime.

Some particulates, such as bacteria and protozoa, can affect humanhealth. Such particulates are normally removed or neutralized as a partof the water treatment processes applied to water used for municipal orhousehold purposes. Because some particulate pathogens, such asCryptosporidium organisms are resistant to most common chemical waterdisinfection treatments, it is necessary to rely on filtration to removeenough of the organisms to meet the applicable water quality standards.

Protozoa such as Cryptosporidium and Giardia organisms can cause seriousillness, particularly in individuals having weakened immune systems. Inview of the widespread distribution of municipal water sources, it is ofcritical importance that protozoan contamination of a municipal watersupply be quickly detectable, so that appropriate health warnings can beissued prior to infection of significant numbers of individuals.

Current protozoa detection methods rely on concentration of largevolumes of water and detection of protozoa in the concentrated sampleusing immunological methods (e.g., a fluorescently-labeled antibodywhich binds specifically to a particular protozoan). The results of theimmunological testing must be confirmed by microscopic analysis.

There are numerous shortfalls to immunological detection methods. First,the methods are time-consuming, requiring at least hours to perform. Thespecificity of the method relies entirely on the specificity of theantibody used. If the antibody reacts with numerous targets other thanthe protozoan of interest, then a large number of false positive resultscan be obtained—resulting in unnecessary health alerts, excessiveanalysis of samples, or both. Potentially more seriously, if theantibody reacts with only certain variants of a protozoan, but not witha variant that occurs in the water being sampled, the immunological testcan fail to detect the pathogen even when it is present. Furthermore,current immunological tests cannot differentiate between protozoan cysts(or oocysts) that are infective and those that are not, nor betweenthose which are viable and those that are not. Tests to determinewhether protozoa will reproduce or infect subjects can also be performedby observing infection and reproduction of the protozoa in mice or othersubjects.

Other methods of indicating the presence of protozoan pathogens in watersamples are even less specific. For example, measurements of theturbidity of water samples can provide information regarding the overallcontent of particulates in the water sample, but cannot identify theparticulates. Examination of the presence of indicator organisms (e.g.,fecal coliform bacteria) can indicate occurrence of generalizedcontamination of the water sample, but rely on association of protozoancontamination with fecal contamination.

The methods disclosed in this application overcome the shortcomings ofprior art methods and enable detection of protozoan and otherparticulate contaminants in water samples.

Cryptosporidium

Cryptosporidia are protozoan parasites that can cause severe, acutedisease in humans and other animals when the parasites are ingested.Occurrence of the disease requires reproduction of the parasites in thehost. In healthy humans, the parasites can cause severe diarrhea,cramping, and discomfort. Although most healthy humans recover readilyfrom cryptosporidial infection, immunocompromised individuals (e.g.,humans who are ill, taking immunosuppressing drugs, very old, or veryyoung) can be much more severely affected. As demonstrated in knownoutbreaks, cryptosporidial infection can be fatal to immunocompromisedpatients. There is no specific drug therapy proven to be effective totreat cryptosporidial infections. For these reasons, detection ofcryptosporidia in water supplies is important. It is also important tobe able to distinguish viable and non-viable cryptosporidia andinfectious and non-infectious cryptosporidia.

Environmental sources of cryptosporidia are not exhaustively understood.However, there is a general understanding that at least mostcryptosporidia are transmitted by way of fecal contamination, the fecesbeing of either human or animal origin. For this reason, water sourceswhich may at least occasionally be contaminated with treated oruntreated sewage or with runoff from agricultural animal farms andranches are considered to be at significant risk for contamination withcryptosporidia.

Cryptosporidia may be identified by their reaction with specificantibodies and by their microscopic morphological and stainingcharacteristics. Cryptosporidia occur outside the body of an animalprimarily in the form of oocysts, which are environmentally stable andresistant particles having a diameter that is typically in the rangefrom about 3-6 micrometers. Each oocyst typically contains foursporozoites, each of which can independently infect a host uponingestion by the host of the oocyst. Extended exposure to theenvironment, treatment with certain chemicals, exposure to ultravioletradiation, and other unknown factors can render sporozoites within anoocyst non-viable (i.e., unable to infect a host upon ingestion of theoocyst).

Microscopic examination of oocysts by a trained expert is a currentlyknown method of differentiating viable and non-viable sporozoites. If anoocyst contains no viable sporozoites, then occurrence of the oocyst ina water supply is not a significant health concern. However, it isdifficult to determine by simple microscopic observation whether anoocyst contains any sporozoites, let alone any that are viable. There iscurrently no practical way of differentiating between oocysts thatcontain viable sporozoites and those which do not, at least on the scaleof municipal water treatment. For this reason, the efficacy of watertreatment processes for rendering cryptosporidia sporozoites non-viablecan not be practically assessed, and chemical or physical treat watersupplies to render the sporozoites non-viable cannot be relied upon toproduce potable water. A rapid method of differentiating viable andnon-viable cryptosporidial sporozoites could render such treatmentspractical. The present invention overcomes this difficulty.

Raman Spectroscopy

Raman spectroscopy provides information about the vibrational state ofmolecules. Many molecules have atomic bonds capable of existing in anumber of vibrational states. Such molecules are able to absorb incidentradiation that matches a transition between two of its allowedvibrational states and to subsequently emit the radiation. Most often,absorbed radiation is re-radiated at the same wavelength, a processdesignated Rayleigh or elastic scattering. In some instances, there-radiated radiation can contain slightly more or slightly less energythan the absorbed radiation (depending on the allowable vibrationalstates and the initial and final vibrational states of the molecule).The result of the energy difference between the incident and re-radiatedradiation is manifested as a shift in the wavelength between theincident and re-radiated radiation, and the degree of difference isdesignated the Raman shift (RS), measured in units of wavenumber(inverse length). If the incident light is substantially monochromatic(single wavelength) as it is when using a laser source, the scatteredlight which differs in frequency can be more easily distinguished fromthe Rayleigh scattered light.

Water exhibits very little Raman scattering, and Raman spectroscopytechniques can be readily performed in aqueous environments. BecauseRaman spectroscopy is based on irradiation of a sample and detection ofscattered radiation, it can be used to analyze water samples with littlepreparation.

An apparatus for Raman Chemical Imaging (RCI) has been described byTreado in U.S. Pat. No. 6,002,476, and in co-pending U.S. patentapplication Ser. No. 09/619,371, the entirety of each of which isincorporated herein by reference.

BRIEF SUMMARY OF THE INVENTION

The invention relates to a method of assessing occurrence of a pathogenin a sample. The method comprises irradiating the sample and assessingradiation scattered from the sample for radiation that exhibits a Ramanscattering characteristic of the pathogen. Detection of scatteredradiation that exhibits a Raman shift characteristic of the pathogen isan indication that the pathogen occurs in the sample.

Examples of pathogens (e.g., human pathogens or those of animals orplants) that can be assessed using the methods described herein includebacteria (including eubacteria and archaebacteria), eukaryoticmicroorganisms (e.g., protozoa, fungi, yeasts, and molds) viruses, andbiological toxins (e.g., bacterial or fungal toxins or plant lectins).Specific examples of such pathogens include protozoa of the genusCryptosporidium, protozoa of the genus Giardia, bacteria of genera suchas Escherichia, Yersinia, Francisella, Brucella, Clostridium,Burkholderia, Chlamydia, Coxiella, Rickettsia, Vibrio, Enterococcus,Staphylococcus, Staphylococcus, Enterobacter, Corynebacterium,Pseudomonas, Acinetobacter, Klebsiella, and Serratia. Assessableorganisms include at least Escherichia coli, Yersinia pestis,Francisella tularensis, Clostridium perfringens, Burkholderia mallei,Burkholderia pseudomallei, Chlamydia psittaci, Coxiella burnetii,Rickettsia prowazekii, Vibrio vulnificus, Vibrio enterolyticus, Vibriofischii, Vibrio cholera, Enterococcus faecalis, Staphylococcusepidermidis, Staphylococcus aureus, Enterobacter aerogenes,Corynebacterium diphtheriae, Pseudomonas aeruginosa, Acinetobactercalcoaceticus, Klebsiella pneumoniae, Serratia marcescens, Candidaalbicans, filoviruses such as Ebola and Marburg viruses, naviruses suchas Lassa fever and Machupo viruses, alphaviruses such as Venezuelanequine encephalitis, eastern equine encephalitis, and western equineencephalitis, rotoviruses, calciviruses such as Norwalk virus, andhepatitis (A, B, and C) viruses.

In an important embodiment, the methods described herein can be used toassess a biological warfare agent. Examples of agents that can beassessed using these methods include at least Bacillus anthracis,Bartonella quintana, Brucella melitensis, Burkholderia mallei,Burkholderia pseudomallei, Chlamydia psittaci, Clostridium botulinum,Clostridium perfringens, Coxiella burnetti, enterohaemorrhagicEscherichia coli, Francisella tularensis, Rickettsia mooseri, Rickettsiaprowasecki, Rickettsia rickettsii, Rickettsia tsutsugamushii, Salmonellatyphi, Shigella dysenteriae, Vibrio cholerae, Yersinia pestis,Coccidioides immitis, Histoplasma capsulatum, chikungunya virus,Congo-Crimean haemorrhagic fever virus, dengue fever virus, Easternequine encephalitis virus, ebola virus, equine morbillivirus, hantaanvirus, Japanese encephalitis virus, junin virus, lassa fever virus,lymphocytic choriomeningitis virus, machupo virus, marburg virus, monkeypox virus, Murray valley encephalitis virus, nipah virus, Omskhemorrhagic fever virus, oropouche virus, Rift valley fever virus,Russian Spring-Summer encephalitis virus, smallpox virus, South Americanhemorrhagic fever viruses, St. Louis encephalitis virus, tick-borneencephalitis virus, Variola virus, Venezuelan equine encephalitis virus,Western equine encephalitis virus, white pox virus, yellow fever virus,botulinum toxins, Clostridium perfringens toxins, microcystins(Cyanginosins), Shiga toxin, verotoxin, Staphylococcal enterotoxin B,anatoxin A, conotoxins, palytoxin, saxitoxin, tetrodotoxin, stachybotrystoxins, aflatoxins, trichothecenes, satratoxin H, T-2 toxin, and ricin.Other examples include Abrus precatorius lectin, African swine fevervirus, avian influenza virus, banana bunchy top virus, bluetongue virus,camelpox virus, cholera toxin, Clostridium perfringens, Clostridiumtetani, Cryptosporidium parvum, Deuterophoma tracheiphila, Entamoebahistolytica, ergot alkaloids, Escherichia coli O157, foot and mouthdisease virus, Giardia lamblia, goat pox virus, hendra virus, hepatitisA virus, hog cholera virus, human immunodeficiency virus, infectiousconjunctivitis virus, influenza virus, Kyasanur Forest virus, Legionellapneumophila, louping ill virus, lyssaviruses, Adenia digitata lectin(modeccin), Monilia rorei, Naegleria fowleri, nipah virus, Murray Valleyencephalitis virus, Mycoplasma mycoides, newcastle disease virus,oropouche virus, peste des petits ruminants virus, porcine enterovirus9, powassan virus, pseudorabies virus, rinderpest virus, rocio virus,group B rotaviruses, Salmonella paratyphi, sheeppox virus, St. Louisencephalitis virus, substance P, Serratia marcescens, Teschen-Talfanvirus, tetanus toxin, vesicular stomatitis virus, Viscum album lectin 1(Viscumin), Adena volkensii lectin (volkensin), West Nile virus,Xanthomonas campestris oryzae, Xylella fastidiosa, and Yersiniapseudotuberculosis.

Examples of plant pathogens that can be assessed using these methodsinclude at least Burkholderia solanacearum, citrus greening diseasebacteria, Erwinia amylovora, Xanthomonas albilineans, Xanthomonasaxonopodis pv. citri, Bipolaris (Helminthosporium) maydis, Clavicepspurpurea, Colletotrichum coffeanum virulans, Cochliobolus miyabeanus,Dothistroma pini, Fusarium oxysporum, Microcystis ulei, Neovossiaindica, Peronospora hyoscyami, Puccinia erianthi, Puccinia graminis,Puccinia graminis f. sp. tritici, Puccinia striiformis, Pyriculariagrisea, Sclerotinia sclerotiorum, Sclerotium rolfsii, Tilletia indica,Ustilago maydis, Phytophthora infestans, and Fiji disease virus.

In addition to assessing occurrence of a pathogen in a sample, themethods described herein can be used to distinguish among variouspathogens, to distinguish between viable and non-viable forms of thesame pathogen, and to distinguish between infectious and non-infectiousforms of the same pathogen. Furthermore, the assessment methodsdescribed herein can be coupled with pathogen-ablating methods to ablateor eliminate pathogens from a sample.

BRIEF SUMMARY OF THE SEVERAL VIEWS OF THE DRAWINGS

FIG. 1 is a schematic diagram of an embodiment of the Raman chemicalimaging system more fully described in U.S. Pat. No. 6,002,476.

FIGS. 2A and 2B are microscopic fluorescence-spectroscopic images of twodifferent bacterial spore types (Bacillus pumilis ROI1 in FIG. 2A; B.subtilis ROI2 in FIG. 2B) recorded at different wavelengths, and FIG. 2Cis a fluorescent spectrum for the two spore types.

FIG. 3, comprising FIGS. 3A, 3B, 3C, and 3D, shows a Raman chemicalimage of Bacillus globigii spores mixed with baking soda and SWEET-N-LOW(RTM) brand saccharin (FIG. 3C). The three components can readily bediscriminated by their Raman spectra (FIG. 3D). Brightfield (FIG. 3A)and polarized light (FIG. 3B) images are shown for reference.

FIG. 4 is a comparison of the Raman spectra of three different strainsof Bacillus anthracis spores. This figure indicates that Raman spectralanalysis can be applied to distinguish between multiple bacterialstrains within a single species.

FIG. 5 is a comparison of the Raman spectra of viable, non-viable, andformalin-treated Bacillus cereus spores. This figure indicates thatRaman spectral analysis can be applied to distinguish between viable andnon-viable organisms.

FIG. 6, comprising FIGS. 6A and 6B, are a brightfield image (100×magnification) and a dispersive Raman spectrum, respectively, ofsubstantially pure Cryptosporidium parvum oocysts on an aluminumsupport.

FIG. 7, comprises FIGS. 7A, 7B, and 7C. FIGS. 7A and 7B are abrightfield image (100× magnification), a dispersive Raman spectrum ofthe entire field shown in the brightfield image, respectively, of asample containing Cryptosporidium parvum oocysts and typical river waterinterferents on an aluminum support. FIG. 7C is a dispersive Ramanspectrum of a comparable field containing only normal interferentsobtained from the same river.

FIG. 8 comprises FIGS. 8A, 8B, 8C, and 8D. FIG. 8A is a brightfieldimage (100× magnification) of substantially pure Cryptosporidium parvumoocysts on an aluminum support. FIG. 8B is a Raman chemical image(assessed at a Raman shift value of 1450 centimeters⁻¹ of themicroscopic field shown in FIG. 8A. FIG. 8C is an overlay of the imagesshown in FIGS. 8A and 8B. FIG. 8D is a Raman spectrum obtained from theboxed area of the image shown in FIG. 8B.

FIG. 9 comprises FIGS. 9A, 9B, and 9C. FIG. 9A is a brightfield image(100× magnification) of substantially pure Cryptosporidium parvumoocysts on an aluminum support. FIG. 9B is a Raman chemical image(assessed at a Raman shift value of 1310 centimeters⁻¹ of themicroscopic field shown in FIG. 9A. FIG. 9C is a pair of Raman spectraobtained from the boxed areas of the image shown in FIG. 9B—onecorresponding to an area including an apparent C. parvum oocyst, theother corresponding to an area apparently lacking any C. parvum oocyst.

FIG. 10 is a set of four vertically offset dispersive Raman spectraobtained separately from oocysts of Cryptosporidium muris and C. parvum.Oocysts indicated as “dead” were treated with formalin. Oocystsindicated as “live” were not so treated.

DETAILED DESCRIPTION OF THE INVENTION

The invention is based, in part, on the discovery that irradiation of awater sample containing a pathogen induces Raman scattering of theapplied radiation by the pathogen. Raman scattered radiationcharacteristic of the pathogen can be detected at very low pathogenloads, and the scattered radiation is not significantly inhibited by thewater or normal constituents of surface water sources.

The methods described herein involve irradiating a water sample, such aswater obtained from a surface water source and concentrated using a 1micron (micrometer) filter, with substantially monochromatic light andassessing Raman light scattering from the sample. The intensity of Ramanlight scattering at one or more Raman shift values can be assessed byitself. However, a more information-rich image can be made by combiningthe Raman scattering data with visual microscopy data to make a hybridimage. In such an image, Raman scattering information can be combinedwith information derived from the visual microscopic image data, and thesuperimposed and/or integrated data sets can be assessed together.

The methods described herein allow quantitative evaluation of pathogenloads in a water sample with relatively little and uncomplicated samplepreparation, or even without sample preparation. The methods are alsocapable of distinguishing viable pathogen cells and particles fromnon-viable cells and particles and infectious pathogen cells andparticles from non-infectious cells and particles. The methods describedherein have important applications, such as for detection ofCryptosporidium organisms in municipal water systems.

Definitions

As used herein, each of the following terms has the meaning associatedwith it in this section.

“Bandwidth” means the range of wavelengths in a beam of radiation, asassessed using the full width at half maximum method.

“Bandpass” of a detector or other system means the range of wavelengthsthat the detector or system can distinguish, as assessed using the fullwidth at half maximum intensity method.

The “full width at half maximum” (“FWHM”) method is a way ofcharacterizing radiation including a range of wavelengths by identifyingthe range of contiguous wavelengths that over which the magnitude of aproperty (e.g., intensity or detection capacity) is equal to at leasthalf the maximum magnitude of that property in the radiation at a singlewavelength.

“Spectral resolution” means the ability of a radiation detection systemto resolve two spectral peaks.

A protozoan sporozoite, cyst, or oocyst is “viable” if the sporozoite(or a sporozoite contained within the cyst or oocyst) is able to infecta normal host of the protozoan upon ingestion by the host of the cyst oroocyst and continue the life cycle of the protozoan, includingproduction of a cyst or oocyst from the sporozoite in the host.

A protozoan sporozoite, trophozoite, cyst, or oocyst is “infectious” ifthe sporozoite or trophozoite (or a sporozoite or trophozoite containedwithin the oocyst or cyst) is able to infect a normal host of theprotozoan upon ingestion by the host of the cyst or oocyst and cause aclinical symptom of infection by the protozoan.

A “characteristic dimension” of a pathogen is a geometric size or shapeby which the pathogen can be characterized. By way of example,characteristic dimensions of a straight bar having a constant diameteralong its length include the length of the bar, the diameter of the bar,and the volume swept out by the bar when it rotates in space randomlyabout its center of mass.

Detailed Description

Raman Spectroscopic Analysis for Detection of Pathogens in Water

The invention is based, in part, on the discovery that irradiation of awater sample containing a pathogen induces Raman scattering of theapplied radiation by the pathogen. Raman scattered radiationcharacteristic of the pathogen can be detected at very low pathogenloads, and the scattered radiation is not significantly inhibited by thewater or normal constituents of surface water sources.

The method can be exemplified using Cryptosporidium oocysts as anexample of the pathogen to be detected. In order to assess occurrence ofa Cryptosporidium oocyst in a water sample (or in any other aqueoussample), the sample is irradiated and radiation scattered from thesample is assessed for radiation that exhibits a Raman scatteringcharacteristic of Cryptosporidium oocysts. Detection of scatteredradiation that exhibits a Raman shift characteristic of Cryptosporidiumoocysts is an indication that a Cryptosporidium oocyst occurs in thesample. A Raman spectrum of Cryptosporidium parvum oocysts is shown inFIG. 6. Similar spectra can be obtained for any water-borne pathogenusing the methods disclosed herein and/or known in the art.

In order to assess whether an entity in a water sample is a pathogen,any of a variety of Raman scattering characteristics of the pathogen canbe used. Such characteristics can be identified by assessing the Ramanscattering behavior of a pure culture of the pathogen if they are notpreviously known. Because Raman scattering characteristics of pathogensare substantially invariant from sample to sample, the characteristicsof a pathogen of interest can be stored (e.g., by recordingcharacteristic Raman shift (RS) values in a computer memory device). Ifa source of the pathogen of interest is known (e.g., runoff from aparticular farm or wastewater treatment facility), then a sampleobtained directly from that source can be assayed as a control toaccount for any minor variations that might be attributable to localconditions.

An example of a suitable Raman spectral characteristic that can be usedto identify a pathogen in a water sample is a Raman shift (RS) valuecharacteristic of the pathogen. Such RS values can be detected in anysuitable range, based on the detection equipment used. For example, theequipment described herein and in the patent documents incorporatedherein by reverence can be used to detect RS values in the range fromnear zero to 3500 cm⁻¹ (or 500 to 3250 cm⁻¹). In order to avoid Ramanspectral characteristics of interferents, for example, a plurality ofdiscontinuous Raman spectra may be obtained, such as spectra from 250 to1800 cm⁻¹ (or 1000 to 1700 cm⁻¹) and from 2700 to 3500 cm⁻¹ (or 2700 to3200 cm⁻¹).

Confidence in the identification of a particle in a water sample as apathogen of interest can be increased by assessing Raman spectral dataat more than one RS value, such as by assessing scattering at two RSvalues or over a spectrum of RS values. Other informative measuresinclude comparing ratios of Raman scattering intensity at two RS valuesor at multiple pairs of RS values, such values being comparable withknown values or values obtained from a reference sample. Furtherinformation can be derived by comparing the shapes of one or more Ramanscattering intensity peaks with peaks in known reference spectra orspectra obtained from one or more reference samples. By way of specificexample, Cryptosporidium parvum oocysts can be detected by assessing thesample at one or more Raman shift values at which peaks are seen in FIG.6, such as one or more RS values of about 1000, 1080, 1310, 1330, 1450,1660, 2720, and 2930 cm⁻¹. Other RS values which can be assessed to aididentification include values of about 482, 715, 778, 858, 938, severalpeaks forming a broad band between 1012 and 1179, several peaks forminga broad band between 1175 and 1415, 1270, 1555, 1575, 1610, severalpeaks forming a broad band between 1620 and 1783,1650, 2620, and a broadband between 2785 and 3180 cm⁻¹.

Where interferents of known or predictable composition are present inthe water sample, it can be advantageous to avoid assessing Ramanspectral information at RS values characteristic of the interferents.For example, FIG. 7A shows a microscopic image of a single C. parvumoocyst in a sample containing river water interferents. A dispersiveRaman spectrum of the entire field of view of FIG. 7A is shown in FIG.7B. The presence of interferents can be seen by comparing the Ramanspectra of FIGS. 7B and 6B.

There are multiple ways of obtaining useful information regardingoccurrence of a pathogen in a sample containing interferents, such asthe sample used to generate the information shown in FIG. 7. Forexample, an RS value at which the pathogen exhibits a greater intensityof Raman scattering than the interferent (e.g., RS=ca. 2930centimeters⁻¹ in FIG. 7B) can be used to assess occurrence of thepathogen.

Alternatively, Raman spectral analysis can be performed on a narrowerfield in order to obtain a more detailed image of the composition of thecomponents in the field. By way of example, the brightfield image inFIG. 7A shows an area measuring approximately 20×30 micrometers (i.e.,ca. 600 square micrometers). If 600 square-micrometer sections of awater sample were assayed for significant Raman scattering, thensections (e.g., that shown in FIG. 7A) that exhibit significant Ramanscattering intensity at an RS value characteristic of C. parvum can beselected for finer-scale Raman analysis. For example, the spatialresolution of the Raman chemical imaging system disclosed in U.S. Pat.No. 6,002,476 is on the order of 250 nanometers. Thus, sub-portions ofan area such as that shown in FIG. 7A can be assessed at a resolutionapproaching ⅛ of a square micrometer. An iterative assessment scheme canbe used, wherein Raman scattering analyses are made for portions andsub-portions of decreasing size, the assessments being made only forportions and sub-portions which exhibited a pathogen-consistent Ramanscattering property in the previous iteration.

As yet another alternative, subtractive Raman spectroscopy can beperformed, wherein Raman scattering can be assessed for a control sampleknown (e.g., by intensive microscopic analysis and/or immunologicaltesting) to be devoid of the pathogen. The Raman scattering dataobtained from that control sample (or from an averaged plurality of suchcontrol samples, for example) can be subtracted from samples obtainedfrom similar sources (i.e., sources in which the same interferents wouldbe expected, such as the same reservoir) in order to assess occurrenceof the pathogen in those samples. In a variant of this method, separateRaman spectral data sets can be gathered from a portion of a microscopicimage that is consistent with the presence of a pathogen (e.g.,occurrence of 2-6 micrometer diameter spheres if assessing occurrence ofC. parvum) and from one or more portions of the same image that are notconsistent with the presence of the pathogen (e.g., absence of C.parvum-like spheres).

As shown in FIGS. 5 and 10, viable and non-viable forms of a pathogencan be differentiated by their Raman spectra. This characteristicenables discrimination between viable and non-viable pathogen cells orparticles in a water sample. For example, the methods can be used toassess a Raman scattering characteristic that is exhibited by viableCryptosporidium oocysts, but not (or to a lesser degree) by non-viableoocysts, or vice versa. Similarly, Raman spectral differences betweeninfectious and non-infectious oocysts can be exploited to differentiatebetween those forms. By way of example, differences in Raman spectralintensities at RS values of about 970, 1000, 1050, and 1610centimeters⁻¹ can be used to distinguish viable from non-viable oocysts.

Sample Preparation

The methods described herein involve assessing light scattered by asample. For that reason, the methods can be performed on wide variety ofsamples. No formal sample preparation is necessary. The methods can beperformed using a water sample drawn directly from a source.Alternatively (and preferably in situations in which any pathogen isexpected to be present in minute quantities, if present at all), a watersample taken from a source can be concentrated prior to Raman spectralanalysis of the concentrated sample. Alternatively, particles in a watersample can be collected on a surface, such as by filtering the samplethrough the surface (e.g., using a 1-micron pore size filter medium),drying the sample against the surface, centrifuging the sample todeposit particles contained therein on the surface, precipitatingparticles in the sample onto the surface, or some combination of these.Such surfaces can be subjected to Raman spectral analysis in a wet,dehumidified, or dried state.

Raman scattering by articles on or above a surface can be assessedthrough three dimensions. The instruments described herein and in U.S.Pat. No. 6,002,476 gather Raman scattered light from a single plane thatis arranged in focus with a scattered light detector. By varying thefocal plane, Raman scattering from particles in different planes can beassessed. When the focal planes that are scattered are nearer to oneanother than the size of a particle (e.g., a C. parvum oocyst has atypical diameter of about 5 micrometers), then Raman spectralinformation about the interior of the particle can be obtained. By wayof example, if Raman spectral data are obtained at multiple parallelfocal planes that intersect a C. parvum oocyst, then the Ramancharacteristics (including viability-correlated Raman characteristics)of the sporozoites can be distinguished from one another. In this way, amore accurate assessment of the total number of viable sporozoites in apopulation of oocysts can be obtained. This information can be used toassess the efficacy of viability-inhibiting agents on C. parvumsporozoites. In view of the fact that even a single viable sporozoitecontained within a cryptosporidial oocyst can infect a subject, thislevel of detail is not required. In many instances, it is sufficient toassess whether cryptosporidial oocysts contain any viable sporozoites atall.

When particles in a water sample are assessed on a surface, the surfacecan be substantially any material that does not significantly interferewith Raman spectral analysis. Examples of suitable surfaces arefiltration media, ultrafiltration membranes, aluminum-coated glassslides of the type commonly used for Raman spectral analysis, and media(e.g. surfaces coated with colloidal metal particles, such as colloidalgold or silver particles) designed to enhance Raman spectral signals.All of these surfaces are known in the art.

The methods described herein can be used to assess aqueous samples(whether concentrated or not), non-aqueous fluid samples, dry samples,and combinations of these. Substantially any sample which permitsirradiation of the pathogen to be detected and detection of radiationscattered thereby can be assessed using these methods. A surface ormaterial can be assessed directly (e.g., using an instrument thatcontacts or contains the surface or material) or by assessing a samplingmaterial brought into contact with the surface or sample (e.g., a fluidused to rinse a surface or a woven or non-woven fabric swiped along ortouched to a surface). The samples can be ambient samples obtained froman outdoor environment, an archive of particulate materials collected bya particle collector, or samples obtained from a human or other subject(e.g., urine, feces, blood serum, or animal or plant tissue), forexample. The identity of the sample that is assessed using the methodsdescribed herein is not critical to the operation of the methods.

Pathogens

The methods described herein can be used to assess occurrence in asample (e.g., in a water sample) of substantially any pathogen thatexhibits an identifiable Raman spectral characteristic. Examples ofpathogens that can be detected in samples using the methods describedherein include protozoa such as those of the genus Cryptosporidium andthe genus Giardia; bacteria such as Escherichia coli, Yersinia pestis,Francisella tularensis, Brucella species, Clostridium perfringens,Burkholderia mallei, Burkholderia pseudomallei, Chlamydia psittaci,Coxiella burnetii, Rickettsia prowazekii, Vibrio species; Enterococcusfaecalis; Staphylococcus epidermidis; Staphylococcus aureus;Enterobacter aerogenes; Corynebacterium diphtheriae; Pseudomonasaeruginosa; Acinetobacter calcoaceticus; Klebsiella pneumoniae; Serratiamarcescens; yeasts such as Candida albicans; and viruses, includingfiloviruses such as Ebola and Marburg viruses, naviruses such as Lassafever and Machupo viruses, alphaviruses such as Venezuelan equineencephalitis, eastern equine encephalitis, and western equineencephalitis, rotoviruses, calciviruses such as Norwalk virus, andhepatitis (A, B, and C) viruses, and biological warfare agents such assmallpox (i.e., variola major virus). The methods described herein canbe used to distinguish between viable and non-viable forms of theseorganisms and between infectious and non-infectious forms.

An important group of organisms which the methods described herein areuseful for detecting are protozoa of the genus Cryptosporidium. At leastseveral species of cryptosporidia are potentially pathogenic in humans,including Cryptosporidium parvum (common host: humans), Cryptosporidiummuris (common host: mice), Cryptosporidium meleagridis (common host:turkeys), Cryptosporidium wrairi (common host: guinea pigs),Cryptosporidium felis (common host: cats), Cryptosporidium serpentis(common host: snakes), Cryptosporidium nasorum (common host: fish),Cryptosporidium baileyi (common host: chickens), Cryptosporidiumsarophilum (common host: lizards), Cryptosporidium canis (common host:dogs), and Cryptosporidium andersoni (common host: cattle). The methodsdescribed herein are useful for detecting each of these species ofCryptosporidium. Using pure cultures as standards, for example, many, ifnot all, of these species can be differentiated from one another usingthe methods described herein.

The methods described herein can be used to distinguish differentspecies of cryptosporidia or other organisms. The methods can also beused to differentiate organisms within a species that belong todifferent varieties of the species, are at different stages of theirlife cycles (e.g., organisms that are motile, rapidly dividing,sporulating, hibernating, and the like). Many species and varieties ofcryptosporidia and other pathogens are normally harbored by host animalsof a certain genus or even species. By detecting the particular speciesor variety of a pathogen such as a Cryptosporidium in a water source, itis possible to obtain information regarding a likely source or likelysources of the pathogens in the water. By way of example, detection ofC. andersoni oocysts in a lake suggests that runoff from an agriculturalranch in the lake's watershed may be a source of the oocysts. Anyintraspecies differences that can be detected using the methodsdescribed herein can furthermore be used to localize a pathogen to aparticular source or environment if those differences can be correlatedwith the source or environment.

Pathogen Ablation and Manipulation

In addition to identifying pathogens at one or more particular locationsin a sample, the methods described herein can be used to manipulate theportion of the sample containing the identified pathogen. Pathogensidentified using these methods can be ablated or manipulated bydirecting appropriate ablation or manipulation modalities to the portionof the sample containing the pathogen. By way of example, laser light ofsufficient intensity to ablate (i.e., lyse or render non-infectious ornon-viable) a Cryptosporidium oocyst can be directed to a portion of asample at which such an oocyst was detected. The same effect can beachieved by activating a heating element which underlies the portion ofthe sample in which the pathogen was detected. Similarly, a fluid- orparticle-collecting device can be directed to the pathogen-containingportion of the sample for the purpose of collecting the pathogen.Alternatively, a radiation source can be activated to melt, orchemically activate, a portion of the substrate adjacent a detectedpathogen in order to fix the pathogen to the substrate.

In another embodiment, Raman spectral analysis can be performed on afluid medium contained on or in a microfluidic circuit, such as one ofthose described in the co-pending patent application filed 18 Aug. 2004by Tuschel et al. and entitled “Method and Apparatus of Chemical Imagingin a Microfluidic Circuit.” The results of such analysis can be sent toa controller which can control the disposition of fluid in the circuitbased on such results, for example.

Raman Spectral Analysis

In order to detect Raman scattered light and to accurately determine theRaman shift of that light, the water sample should be irradiated withsubstantially monochromatic light, such as light having a bandwidth notgreater than about 1.3 nanometers, and preferably not greater than 1.0,0.50, or 0.25 nanometer. Suitable sources include various lasers andpolychromatic light source-monochromator combinations. It is recognizedthat the bandwidth of the irradiating light, the resolution of thewavelength resolving element(s), and the spectral range of the detectordetermine how well a spectral feature can be observed, detected, ordistinguished from other spectral features. The combined properties ofthese elements (i.e., the light source, the filter, grating, or othermechanism used to distinguish Raman scattered light by wavelength)define the spectral resolution of the Raman signal detection system. Theknown relationships of these elements enable the skilled artisan toselect appropriate components in readily calculable ways. Limitations inspectral resolution of the system (e.g., limitations relating to thebandwidth of irradiating light) can limit the ability to resolve,detect, or distinguish spectral features. The skilled artisanunderstands that and how the separation and shape of Raman scatteringsignals can determine the acceptable limits of spectral resolution forthe system for any of the Raman spectral features described herein.

In general, the wavelength and bandwidth of light used to illuminate thesample is not critical, so long as the other optical elements of thesystem operate in the same spectral range as the light source. For adiffraction grating, the spectral resolution is defined as the ratiobetween the wavelength of interest and the separation, in the same unitsas the wavelength, required to distinguish a second wavelength. With abroader source (or a source filter enabling passage of light exhibitingan intensity profile characterized by a greater full width halfmaximum), greater peak separation is required, because the Raman peaksare more blurred on account of the greater variety of irradiatingwavelengths that are shifted. Such a system would have a lower Ramanpeak resolving power. An ordinarily skilled artisan can calculate theminimum resolving power required for distinguishing two Raman peaks.

The source of substantially monochromatic light is preferably a lasersource, such as a diode pumped solid state laser (e.g., a Nd:YAG orNd:YVO₄ laser) capable of delivering monochromatic light at a wavelengthof 532 nanometers. Other lasers useful for providing substantiallymonochromatic light having a wavelength in the range from about 220 to1100 nanometers (or in a narrower range, such as 280 to 695 nanometers)include HeNe (630 nanometers), argon ion (532 nanometers), argon gas(360 nanometers), HeCd (442 nanometers), krypton (417 nanometers), andGaN (408 nanometers, although doped GaN lasers can provide 350nanometers). Other lasers can be used as well, such as red diode lasers(700-785 nanometers) and eximer lasers (200-300 nanometers). Knownfrequency-doubling or—tripling methods can be used in conjunction withlasers (e.g., argon or YAG lasers) to produce shorter wavelengths andoptically coherent light. Use of ultraviolet irradiation can permit useof resonance Raman techniques, which can yield more intense signals andsimplified spectral peaks. However, lasers capable of ultravioletirradiation tend to be very costly and complex to use, limiting theirdesirability. Such lasers also tend to photodegrade biomaterials,rendering them unsuitable for some applications.

Because Raman scattering peaks are substantially independent of thewavelength of the illumination source, the wavelength of light used toirradiate the cells is not critical. However, the illuminationwavelength influences the intensity of the Raman peaks, the fluorescentbackground signals detected, and the susceptibility to laser-inducedphotodegradation.

Wavelengths at least as low as about 500 nanometers (e.g., from 350 to695 nanometers), and likely as low as 220 or 280 nanometers, can beused. Because the intensity of scattered light is known to be dependenton the fourth power of the frequency (i.e., inverse wavelength) of theirradiating light, and only proportional to the intensity of theirradiating light, lowering the wavelength of the irradiating light canhave the effect of increasing scattering signal output even if theintensity of the irradiating light is decreased. Thus, even underconstant illumination, cells can survive irradiation if the intensity ofthe irradiating light is carefully controlled. Irradiation using evenshorter wavelengths can be performed without harming the illuminatedcells if intermittent or very short duration irradiation methods areemployed. If survival of pathogen cells or oocysts beyond the time ofdetection is not critical, then the effect of irradiating light on thepathogen need not be considered, at least so long as the Raman spectralfeatures are not significantly affected.

An appropriate irradiation wavelength can be selected based on thedetection capabilities of the detector used for assessing scatteredradiation. Most detectors are capable of sensing radiation only in acertain range of frequencies, and some detectors detect frequencies incertain ranges less well than they do frequencies outside those ranges.In view of the Raman shift values that can be expected from pathogens inwater samples, as disclosed herein, many combinations of light sourcesand detectors will be appropriate for use in the systems and methodsdescribed herein. By way of example, front- and back-illuminated siliconcharge coupled device (CCD) detectors are useful for detecting Ramanscattered light in combination with irradiation wavelengths describedherein.

Assessment of Raman scattered light can be measured using any knowndetector appropriate for sensing radiation of the expected wavelength(i.e., about 5 to 200 nanometers greater than the wavelength of theirradiating radiation, or near zero to 500 nanometers for otherdetectors). In view of the relatively low intensities of many Ram anscattered light signals, a highly sensitive detector, such as one ormore cooled charge-coupled device (CCD) detectors. For paralleloperation, CCD detectors having multiple pixels corresponding todiscrete locations in the field of illumination can be used to enablesimultaneous capture of spectroscopic data at all pixel locations in theCCD detector.

A sample can be irradiated by the light source in a diffuse or focusedway, using ordinary optics. In one embodiment, light from the source isfocused on a narrow portion of the sample and Raman scattering from thatportion is assessed. In another embodiment, the light used to irradiatethe sample is focused on a larger portion of the sample (e.g., a portionlarge enough to include multiple pathogen particles) or the entiresample. Wide-field illumination allows the acquisition of data andassessment of Raman scattering across the illuminated field or, ifcoupled with wide-field, massively parallel detectors, can permit rapidRaman scattering analysis across all or part of the illuminated field.In contrast, scanning spot methods to detect Raman scattering requirehigh laser power densities focused into a small region.

The maximum useful power density of irradiation depends on the need forpost-Raman scattering use of any pathogen particles that may be detectedand the anticipated duration of irradiation. The duration and powerdensity of irradiation must not combine to render the irradiatedpathogen particles unsuitable for any desired post-assessment use. Theskilled artisan is able to selected irradiation criteria sufficient toavoid these effects.

Spectral image analysis of Raman scattering on the scale of individualpathogen cells, oocysts, or viruses can be performed using knownmicroscopic imaging components. High magnification lenses are preferred,owing to their higher light collection relative to low magnificationlenses. The numerical aperture of the lens determines the acceptanceangle of light into the lens, so the amount of light collected by thelens varies with the square of the numerical aperture for a fixedmagnification. The magnification also determines how much of the laserilluminated area can be observed in the lens. In view of the fact thatRaman scattered light can have a relatively low magnitude, selection ofan appropriate lens can improve low level signal detection.

Pathogen particles can include many chemical species, and irradiation ofsuch particles can result in Raman scattering at a variety ofwavelengths. In order to determine the intensity of Raman scatteredlight at various RS values, scattered light corresponding to other RSvalues must be filtered or directed away from the detector. A filter,filter combination, or filter mechanism interposed between theirradiated sample and the detector. The system (i.e., taking intoaccount the bandwidth of the irradiating radiation and the bandpass ofany filter or detector) should exhibit relatively narrow spectralresolution (preferably not greater than about 1.3 nanometers, and morepreferably not greater than about 1.0, 0.5, or 0.25 nanometers) in orderto allow accurate definition and calculation of RS values for closelyspaced Raman peaks. If selectable or tunable filters are employed, thenthey preferably provide high out-of-RS band rejection, broad freespectral range, high peak transmittance, and highly reproducible filtercharacteristics. A tunable filter should exhibit a spectral resolvingpower sufficient for Raman spectrum generation (e.g., a spectralresolving power preferably not less than about 12-24 cm⁻¹; higher andlower values can be suitable, depending on the bandwidth of irradiatingradiation and the Raman shift values desired to be distinguished).

A tunable filter is useful when Raman scattering measurements atmultiple wavelengths at multiple locations simultaneously and when aRaman spectrum is to be obtained using the detector (e.g., forcollecting 2-dimensional RS data from a sample). A variety of filtermechanisms are available that are suitable for these purposes. Forexample, an Evans split-element liquid crystal tunable filter (LCTF)such as that described in U.S. Pat. No. 6,002,476 is suitable. An LCTFcan be electronically controlled to pass a very narrow wavelength bandof light. The spectral resolving power of 8 cm⁻¹ (0.25 nanometer) issuitable to perform Raman spectroscopy, and the image fidelity issufficient to take full advantage of the resolving power of a lightmicroscope, yielding a resolution of better than 250 nanometers. Othersuitable filters include Fabry Perot angle-rotated or cavity-tunedliquid crystal (LC) dielectric filters, other LC tunable filters (LCTF)such as Lyot Filters and variants of Lyot filters including Solcfilters, acousto-optic tunable filters, and polarization-independentimaging interferometers such as Michelson, Sagnac, Twynam-Green, andMach-Zehnder interferometers.

Pathogen particles to be analyzed as described herein can be placed onand secured to a surface to prevent movement during analysis. This isparticularly important if Raman spectroscopy and light microscopy dataare to be combined, because it is important to be able to correlate themicroscopic characteristics of the pathogen particles, as directly orindirectly (e.g., using computer-processed or -stored image data)observed with the Raman scattering exhibited by the same particles.Particles can be secured or fixed on a surface using substantially anyknown technique, and any reagents known to exhibit strong Ramanscattering at RS values characteristic of a pathogen of interest shouldbe avoided or accounted for in scattering intensity determinations.Pathogens can be secured or fixed as individual particles on asubstrate, as a substantially flat layer of particles on a substrate, oras a three-dimensional mass of particles. When a secured or fixedparticle preparation includes particles at different elevations abovethe surface of the substrate, spatial analysis of the preparation ispossible using known adaptations to light microscopy and Ramanscattering methods. By way of example, Raman scattering can becorrelated with height above the substrate by assessing Raman scatteringusing different planes of focus. Information obtained at the variousplanes can be reconstructed (e.g., using a computer for storage anddisplay of the information) to provide a two- or three-dimensionalrepresentation of the sample.

Combining Raman Analysis and Other Optical Techniques

The methods described herein for assessing Raman scatteringcharacteristics of pathogen particles that may occur in a sample can besupplemented with other optical techniques for assessing the particles.By way of example, data from light microscopy of a sample can becombined with Raman scattering data, as shown in FIGS. 8 and 9.Alternatively, or in addition, data generated from fluorescencespectroscopy can be combined with Raman scattering data to furthercharacterize the Raman scattering particles. It is known that livingorganisms (and many dormant or dead organisms) exhibit characteristicfluorescence, often over a broad spectral range. Such fluorescence canbe used to identify portions of a sample which appear to harborbiological material, potentially speeding analysis by permitting one tolimit Raman scattering analysis to those portions.

Raman scattered light can be assessed at individual points in a sample,or an optical image of the Raman scattered light can be generated usingconventional optics. The Raman data or image can be visually displayedalone or in combination with (e.g., superimposed upon) a microscopicimage of the sample. Conventional methods of highlighting selected Ramandata (e.g., by color coding or modulating the intensity of Ramanscattered light) can be used to differentiate Raman signals arising fromvarious parts of the sample. By way of example, the intensity of Ramanscattered light having a Raman shift of 2930 cm⁻¹ can be displayed invarying shades or intensity of green color, superimposed on abrightfield image of the sample. In this way, Raman scattering can becorrelated with microscopic landmarks in the sample.

Combining Raman spectroscopy and visual light microscopy techniquesenhances the usefulness of each by adding context to the informationgenerated by the separate methods. Thus, morphological and structuralinformation derivable from microscopic examination can be understood inthe context of the biochemical makeup of the corresponding cellularmaterials and Raman scattering-based clues to the identity of particlesdetected in a water sample. Under appropriate circumstances, staining orlabeling reagents can be used in combination with Raman scattering andlight microscopy in order to yield further information about theparticles.

Substantially any Raman spectrometer capable of defining, detecting, orcapturing data from water samples (including residues from dried,filtered, or concentrated water samples) can be used to generate theRaman scattering data described herein. Likewise, substantially anylight microscopy instrument can be used to generate visible lightmicroscopy information. In circumstances in which positions of particlesin the sample can be correlated (e.g., by analysis of particle positionsand/or morphologies or by analysis of indicia on or shape of thesubstrate), it is not necessary that the Raman and microscope beintegrated. In such circumstances, the data collected from eachinstrument can be aligned from separate observations. Preferably,however, a single instrument includes the Raman spectroscopy and lightmicroscopy functionalities, is able to perform both analyses on a samplewithin a very short time period, and is able to correlate the spatialpositions assessed using the two techniques. Information gathered usingsuch an instrument can be stored in electronic memory circuits,processed by a computer, and/or displayed together to provide adepiction of the cell sample that is more informative that the separatedepictions of the information obtained by the two techniques. A suitableexample of equipment having these characteristics is the FALCON (RTM)RMI microscope available from ChemImage Corporation (Pittsburgh, Pa.).Suitable instruments are also described in U.S. Pat. No. 6,002,476 andin co-pending U.S. patent application Ser. No. 09/619,371.

An example of a probe suitable for in vivo analysis of cells in a bulkwater sample is described in co-pending U.S. patent application Ser. No.10/184,580 (publication no. US 2003/0004419 A1, which is incorporatedherein by reference). The tip of the probe can be inserted into a watersample and Raman scattering and visible microscopic image data can becollected therefrom, optionally at various discrete depths usingfocusing techniques and/or at various RS values. Substantially any fiberoptic or other optical probe that can deliver irradiation to a sampleand collect Raman light scattered therefrom can be adapted to anappropriate Raman spectrometer to perform the methods described herein.The probe preferably also includes an optical channel (e.g., a commonoptical fiber or a separate one) to facilitate microscopic imaging ofthe same sample for which Raman spectroscopy is performed.

Information generated from Raman spectroscopy and/or light microscopy asdescribed herein can be stored in electronic memory circuits, such asthose of a computer, for storage and processing. A wide variety of dataanalysis software packages are commercially available. Suitable types ofsoftware include chemometric analysis tools such as correlationanalysis, principle component analysis, factor rotation such asmultivariate curve resolution, and image analysis software. Suchsoftware can be used to process the Raman scattering and/or visibleimage data to extract pertinent information that might otherwise bemissed by univariate assessment methods.

EXAMPLES

The invention is now described with reference to the following Examples.These Examples are provided for the purpose of illustration only, andthe invention is not limited to these Examples, but rather encompassesall variations which are evident as a result of the teaching providedherein.

FIG. 4 shows how fluorescence spectroscopic imaging can be used todistinguish between bacteria spore types. The fluorescence spectra inthe lower portion of the figure were obtained from the color-coded boxedregions in the concatenated fluorescence spectroscopic images above. Itcan be seen that Bacillus subtilis spores and Bacillus pumilus sporesexhibit fluorescence peaks maxima at 540 nm and 630 nm, respectively.

Advanced image analysis and chemometric tools take these differences influorescence spectra and perform a spatial identification of species,producing the image in FIG. 4. The following is a representativealgorithm for performing this analysis:

1) Divide the raw image by a background image (taken without the sample)

2) Do cosmic filtering on the resultant image (median filtering forpixels whose value differs significantly from the mean of a localneighborhood)

3) Use an alignment procedure to correct for slight movements of thesample during data collection

4) Apply a spatial average filter

5) Perform a spectral normalization (helps correct for varyingillumination across the sample)

6) Perform a spectral running average over each set of three spectralpoints

7) Extract a set of frames corresponding to 550 to 620 nm. The spectrafor both bacterial spores (Bacillus subtilis var niger and Bacilluspumilus) are essentially linear over this range. Bacillus subtilis varniger has a positive slope and Bacillus pumilus has a negative slope.

8) Create a single frame image in which each intensity value is theslope of the spectral sub-region (from the last image). The slope isdetermined via a least-squares fit.

9) Scale the resulting image between 0 and 4095. Keep track of the pointfrom 0 to 4095 that corresponds to 0 in the prior image (the “Zeropoint”).

10) Create a mask image from a series of steps:

10a) From the aligned image (3^(rd) step), calculate a single frame“brightest” image in which the intensity of each pixel is the maximumintensity value for each spectrum.

10b) Scale this brightest image between 0 and 4095.

10c) Create a binarized image from the scaled image, in which everypixel whose intensity is greater than 900 is set to 1 in the new imageand every pixel whose intensity is less than 900 is set to 0 in the newimage. The value of 900 was chosen by an examination of the histogramassociated with the scaled image. A future improvement to the algorithmwould be to automatically select the threshold by numerically analyzingthe histogram for a given image.

11) Multiply the scaled image from step 9 by the mask image from step10. This restricts the visual display to only areas that correspond tospores. The result is a gray scale image in which intensity values belowthe zero point defined in step 9 correspond to bacillus pumilus and theintensity values above the zero point correspond to bacillus subtilisvar niger.

The final RGB image is then created by setting all the “negative” valuesto red and all the “positive” values to green. A similar algorithm canbe used to correlate Raman scattering data with a microscopic image.

An Iowa bovine isolate of C. parvum oocysts was obtained fromexperimentally infected calves (Waterborne, Inc., New Orleans, La.). Theoocysts were obtained in suspension in distilled water, washed withdistilled water, and deposited onto an aluminum-coated glass slide ofthe type typically used for Raman spectroscopy. A microscopic image anddispersive Raman spectrum of the oocysts are shown in FIGS. 6, 8, and 9.The same oocysts, which had been washed with and suspended in a riverwater sample are shown in the image and spectra shown in FIG. 7.

The data in FIG. 10 demonstrate that Raman spectral analysis can be usedto differentiate between viable and non-viable C. parvum oocysts. Theseoocysts were suspended in a solution comprising 5% (v/v) formalin and0.01% (v/v) TWEEN 20 (RTM) detergent to render the oocysts non-viable.

The disclosure of every patent, patent application, and publicationcited herein is hereby incorporated herein by reference in its entirety.

While this invention has been disclosed with reference to specificembodiments, it is apparent that other embodiments and variations ofthis invention can be devised by others skilled in the art withoutdeparting from the true spirit and scope of the invention. The appendedclaims include all such embodiments and equivalent variations.

1. A method of assessing occurrence of a pathogen in a sample, themethod comprising irradiating the sample and assessing radiationscattered from the sample for radiation that exhibits a Raman scatteringcharacteristic of the pathogen, wherein detection of scattered radiationthat exhibits a Raman shift characteristic of the pathogen is anindication that the pathogen occurs in the sample.
 2. The method ofclaim 1, wherein the sample is a fluid sample.
 3. The method of claim 2,wherein the sample is an aqueous sample.
 4. The method of claim 1,wherein the pathogen is a human pathogen.
 5. The method of claim 4,wherein the pathogen is a protozoan.
 6. The method of claim 5, whereinthe pathogen is selected from the group consisting of a protozoan of thegenus Cryptosporidium and a protozoan of the genus Giardia.
 7. Themethod of claim 4, wherein the pathogen is a bacterium.
 8. The method ofclaim 7, wherein the bacterium is a bacterium of a genus selected fromthe group consisting of Escherichia, Yersinia, Francisella, Brucella,Clostridium, Burkholderia, Chlamydia, Coxiella, Rickettsia, Vibrio,Enterococcus, Staphylococcus, Staphylococcus, Enterobacter,Corynebacterium, Pseudomonas, Acinetobacter, Klebsiella, and Serratia.9. The method of claim 7, wherein the bacterium is selected from thegroup consisting of Escherichia coli, Yersinia pestis, Francisellatularensis, Clostridium perfringens, Burkholderia mallei, Burkholderiapseudomallei, Chlamydia psittaci, Coxiella burnetii, Rickettsiaprowazekii, Vibrio vulnificus, Vibrio enterolyticus, Vibrio fischii,Vibrio cholera, Enterococcus faecalis, Staphylococcus epidermidis,Staphylococcus aureus, Enterobacter aerogenes, Corynebacteriumdiphtheriae, Pseudomonas aeruginosa, Acinetobacter calcoaceticus,Klebsiella pneumoniae, and Serratia marcescens.
 10. The method of claim4, wherein the pathogen is a yeast.
 11. The method of claim 10, whereinthe pathogen is Candida albicans.
 12. The method of claim 4, wherein thepathogen is a virus.
 13. The method of claim 12, wherein the virus isselected from the group consisting of filoviruses, naviruses,alphaviruses, rotoviruses, calciviruses, and hepatitis viruses.
 14. Themethod of claim 12, wherein the virus is selected from the groupconsisting of filoviruses such as Ebola and Marburg viruses, navirusessuch as Lassa fever and Machupo viruses, alphaviruses such as Venezuelanequine encephalitis, eastern equine encephalitis, and western equineencephalitis, rotoviruses, calciviruses such as Norwalk virus, andhepatitis (A, B, and C) viruses, and biological warfare agents such assmallpox (i.e., variola major virus)
 15. The method of claim 4, whereinthe pathogen is a biological warfare agent.
 16. The method of claim 15,wherein the pathogen is selected from the group consisting of bacteria,fungi, bacterial toxins, and viruses.
 17. The method of claim 15,wherein the pathogen is selected from the group consisting of Bacillusanthracis, Bartonella quintana, Brucella melitensis, Burkholderiamallei, Burkholderia pseudomallei, Chlamydia psittaci, Clostridiumbotulinum, Clostridium perfringens, Coxiella burnetti,enterohaemorrhagic Escherichia coli, Francisella tularensis, Rickettsiamooseri, Rickettsia prowasecki, Rickettsia rickettsii, Rickettsiatsutsugamushii, Salmonella typhi, Shigella dysenteriae, Vibrio cholerae,Yersinia pestis, Coccidioides immitis, Histoplasma capsulatum,chikungunya virus, Congo-Crimean haemorrhagic fever virus, dengue fevervirus, Eastern equine encephalitis virus, ebola virus, equinemorbillivirus, hantaan virus, Japanese encephalitis virus, junin virus,lassa fever virus, lymphocytic choriomeningitis virus, machupo virus,marburg virus, monkey pox virus, Murray valley encephalitis virus, nipahvirus, Omsk hemorrhagic fever virus, oropouche virus, Rift valley fevervirus, Russian Spring-Summer encephalitis virus, smallpox virus, SouthAmerican hemorrhagic fever viruses, St. Louis encephalitis virus,tick-borne encephalitis virus, Variola virus, Venezuelan equineencephalitis virus, Western equine encephalitis virus, white pox virus,yellow fever virus, botulinum toxins, Clostridium perfringens toxins,microcystins (Cyanginosins), Shiga toxin, verotoxin, Staphylococcalenterotoxin B, anatoxin A, conotoxins, palytoxin, saxitoxin,tetrodotoxin, stachybotrys toxins, aflatoxins, trichothecenes,satratoxin H, T-2 toxin, and ricin.
 18. The method of claim 1, whereinthe pathogen is selected from the group consisting of Abrus precatoriuslectin, African swine fever virus, avian influenza virus, banana bunchytop virus, bluetongue virus, camelpox virus, cholera toxin, Clostridiumperfringens, Clostridium tetani, Cryptosporidium parvum, Deuterophomatracheiphila, Entamoeba histolytica, ergot alkaloids, Escherichia coliO157, foot and mouth disease virus, Giardia lamblia, goat pox virus,hendra virus, hepatitis A virus, hog cholera virus, humanimmunodeficiency virus, infectious conjunctivitis virus, influenzavirus, Kyasanur Forest virus, Legionella pneumophila, louping ill virus,lyssaviruses, Adenia digitata lectin (modeccin), Monilia rorei,Naegleria fowleri, nipah virus, Murray Valley encephalitis virus,Mycoplasma mycoides, newcastle disease virus, oropouche virus, peste despetits ruminants virus, porcine enterovirus 9, powassan virus,pseudorabies virus, rinderpest virus, rocio virus, group B rotaviruses,Salmonella paratyphi, sheeppox virus, St. Louis encephalitis virus,substance P, Serratia marcescens, Teschen-Talfan virus, tetanus toxin,vesicular stomatitis virus, Viscum album lectin 1 (Viscumin), Adenavolkensii lectin (volkensin), West Nile virus, Xanthomonas campestrisoryzae, Xylella fastidiosa, and Yersinia pseudotuberculosis. 19-41.(canceled)
 42. A method of assessing occurrence of a viable biologicalpathogen in a sample, the method comprising irradiating the sample andassessing radiation scattered from the sample for radiation thatexhibits a Raman scattering characteristic of the viable biologicalpathogen, wherein detection of scattered radiation that exhibits a Ramanshift characteristic of the viable biological pathogen is an indicationthat the viable biological pathogen occurs in the sample.
 43. A methodof ablating a viable biological pathogen in a sample, the methodcomprising identifying a viable biological pathogen in a portion of thesample by irradiating the sample, assessing radiation scattered from thesample for radiation that exhibits a Raman scattering characteristic ofthe viable biological pathogen, and thereafter delivering an ablatingagent to the portion. 44-51. (canceled)